SPOTLIGHT: Sanofi says no charges on Plavix


Sanofi-Aventis says it isn't likely to face charges related to Plavix after Bristol-Myers Squibb pleaded guilty to misleading authorities about a failed deal to prevent a generic version of the drug from reaching the market. Report